Drugs Medical Pharma

Blood cancer therapy may help to treat ovarian cancer: Swedish scientists

A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.

Read More
Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

Read More
Medical Pharma

BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine

BioNTech signs MoU with the British government to start mRNA cancer trials

Read More
Drugs Pharma

Aurobindo Pharma gets FDA nod for injection to treat cancer

Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.

Read More
Drugs Pharma

Israeli researchers develop artificially intelligent pathological assistants

Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.

Read More
Drugs Health Medical Pharma

AstraZeneca to buy Neogene for $320 million

AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million

Read More
Drugs Health

Popular variant of Vitamin B3 may cause cancer, finds study

Some vitamins can have fatal side-effects as a new study finds that Niacin may carry risk of brain cancer

Read More
Drugs Health Medical

WHO says 3.5 billion people globally have oral diseases

About 45% of the world’s population, or 3.5 billion people, are suffering from oral diseases, a new study states.

Read More
Drugs Pharma

EMA cracks the whip on JAK inhibitors for inflammatory disorders

The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.

Read More
Drugs Pharma

Aurobindo to recall two drugs with potential cancer risk

HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.

Read More